chlortetracycline

chlortetracycline is a lipid of Polyketides (PK) class. Chlortetracycline is associated with abnormalities such as Granulomatous Disease, Chronic, Infection, Ischemia, Cerebral Ischemia and Cerebral Infarction. The involved functions are known as Regulation, Binding (Molecular Function), Agent, Stimulus and Process. Chlortetracycline often locates in Protoplasm, Plasma membrane, Membrane, Cytoplasm and specific granule. The associated genes with chlortetracycline are FPR1 gene, P4HTM gene, Homologous Gene, HIST1H1C gene and Microbiome. The related lipids are Lysophosphatidylcholines, Sterols, dilauroyl lecithin, seminolipid and Total cholesterol. The related experimental models are Mouse Model.

Cross Reference

Introduction

To understand associated biological information of chlortetracycline, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with chlortetracycline?

chlortetracycline is suspected in Ischemia, Cerebral Ischemia, Cerebral Infarction, Granulomatous Disease, Chronic, Infection, Antibiotic resistant infection and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with chlortetracycline

MeSH term MeSH ID Detail
Body Weight D001835 333 associated lipids
Adenocarcinoma D000230 166 associated lipids
Inflammation D007249 119 associated lipids
Weight Gain D015430 101 associated lipids
Leukemia, Experimental D007942 42 associated lipids
Anemia, Sickle Cell D000755 34 associated lipids
Uremia D014511 33 associated lipids
Diarrhea D003967 32 associated lipids
Bacterial Infections D001424 21 associated lipids
Hyperglycemia D006943 21 associated lipids
Myocardial Infarction D009203 21 associated lipids
Poultry Diseases D011201 21 associated lipids
Escherichia coli Infections D004927 17 associated lipids
Swine Diseases D013553 16 associated lipids
Synovitis D013585 15 associated lipids
Staphylococcal Infections D013203 15 associated lipids
Campylobacter Infections D002169 13 associated lipids
Mycoplasma Infections D009175 13 associated lipids
Corneal Diseases D003316 13 associated lipids
Blood Platelet Disorders D001791 12 associated lipids
Per page 10 20 50 | Total 49

PubChem Associated disorders and diseases

What pathways are associated with chlortetracycline

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with chlortetracycline?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with chlortetracycline?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with chlortetracycline?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with chlortetracycline?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with chlortetracycline?

Mouse Model

Mouse Model are used in the study 'Chlortetracycline and demeclocycline inhibit calpains and protect mouse neurons against glutamate toxicity and cerebral ischemia.' (Jiang SX et al., 2005).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with chlortetracycline

Download all related citations
Per page 10 20 50 100 | Total 4669
Authors Title Published Journal PubMed Link
Galaev IuV and Kharats KS [A study of the activity of L-asparaginase in Escherichia coli of various types]. 1969 Zh. Mikrobiol. Epidemiol. Immunobiol. pmid:4306554
Bakolov AN et al. [The epidemi process in diphtheria in closed children's collectives]. 1966 Zh. Mikrobiol. Epidemiol. Immunobiol. pmid:4242080
DomaradskiÄ­ IV [Iridescent phenomenon in Pseudomonas aeruginosa]. 1975 Zh. Mikrobiol. Epidemiol. Immunobiol. pmid:808057
Ankirskaia AS [The resistance of dysentery bacilli to antibiotics]. 1965 Zh. Mikrobiol. Epidemiol. Immunobiol. pmid:5337069
Gerasimov AV and Mel'nikov VD [Some properties of a bacteriophage active in relation to Proteus pyogenes]. 1967 Zh. Mikrobiol. Epidemiol. Immunobiol. pmid:5597854
Trofimov AM [Experience with the use of Ploskirev's medium with the addition of biomycin in studies on dysentery]. 1968 Zh. Mikrobiol. Epidemiol. Immunobiol. pmid:5731537
Ignatov VV [The nucleotide composition of the DNA of staphylococci resistant to antibiotics]. 1964 Zh. Mikrobiol. Epidemiol. Immunobiol. pmid:5177090
Mordvinova NB and Rogunova KA [The properties of pathogenic staphylococci isolated from healthy children]. 1967 Zh. Mikrobiol. Epidemiol. Immunobiol. pmid:5187238
Shenderov BA and Shcherbakov AA [The interaction between tetracycline and Escherichia coli]. 1973 Zh. Mikrobiol. Epidemiol. Immunobiol. pmid:4595603
FAERMAN NN [Application of biomycin in carriage of Corynebacterium diphtheriae]. 1958 Zh. Mikrobiol. Epidemiol. Immunobiol. pmid:13605092
STEPANISHCHEVA ZG [Changes in the yeasts of the mucous membranes during treatment with biomycin and synthomycin]. 1957 Zh. Mikrobiol. Epidemiol. Immunobiol. pmid:13423819
DIACHENKO IuV [PHAGE TYPING OF STAPHYLOCOCCI ISOLATED FROM CHILDREN WITH PNEUMONIA]. 1964 Zh. Mikrobiol. Epidemiol. Immunobiol. pmid:14255905
TOROSOV TM et al. [THE RESULTS OF BACTERIOLOGICAL EXAMINATION OF THE BILE IN DYSENTERY PATIENTS]. 1963 Zh. Mikrobiol. Epidemiol. Immunobiol. pmid:14151746
KOKHANOVSKAIA TM and POPOVA GO [ANTIOBIOGRAMS OF TYPHOID BACILLI. II. THE COMBINED ACTION OF ANTIBIOTICS ON FRESHLY ISOLATED TYPHOID BACILLUS STRAINS]. 1963 Zh. Mikrobiol. Epidemiol. Immunobiol. pmid:14151772
REDECHKINA ZP [EFFECT OF SOME FACTORS ON THE FORMATION OF THE TYPHOID-PARATYPHOID CARRIER STATE]. 1963 Zh. Mikrobiol. Epidemiol. Immunobiol. pmid:14091789
FAERMAN NN [The use of biomycin in the treatment of patients with pharyngeal diphtheria]. 1960 Zh. Mikrobiol. Epidemiol. Immunobiol. pmid:13697864
SAVITSKAIA EP and ZUBOK LP [Studies on the mechanism of action of biomycin and sekazin on Rickettsia prowazekii]. 1961 Zh. Mikrobiol. Epidemiol. Immunobiol. pmid:13746918
SAVITSKAIA EP [Comparative effects of biomycin and sekazin on Rickettsia prowazekii and mooseri]. 1960 Zh. Mikrobiol. Epidemiol. Immunobiol. pmid:13746919
NADZHIMITDINOV ST [Clinico-immunological indices during biomycin, pentoxyl and vaccine therapy of patients with acute dysentery]. 1961 Zh. Mikrobiol. Epidemiol. Immunobiol. pmid:13727363
AKHUNDOVA KA and SVINKINA NV [Experimental studies on distribution of aureomycin and synthomycin in the organism]. 1954 Zh. Mikrobiol. Epidemiol. Immunobiol. pmid:13157588